|
LIN54 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.417900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.244100E-03 |
| Normal-vs-Stage2 |
7.497800E-01 |
| Normal-vs-Stage3 |
5.70500000000029E-05 |
| Normal-vs-Stage4 |
1.75899999999007E-06 |
| Stage1-vs-Stage2 |
1.755170E-01 |
| Stage1-vs-Stage3 |
8.060400E-02 |
| Stage1-vs-Stage4 |
3.382000E-03 |
| Stage2-vs-Stage3 |
3.463500E-02 |
| Stage2-vs-Stage4 |
6.258500E-03 |
| Stage3-vs-Stage4 |
1.956190E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.74960000000257E-05 |
| Normal-vs-AfricanAmerican |
1.655580E-01 |
| Normal-vs-Asian |
1.175330E-04 |
| Caucasian-vs-AfricanAmerican |
2.247200E-01 |
| Caucasian-vs-Asian |
5.545200E-01 |
| AfricanAmerican-vs-Asian |
2.318800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.423100E-03 |
| Normal-vs-Female |
1.380790E-03 |
| Male-vs-Female |
4.942400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.759600E-03 |
| Normal-vs-Age(41-60Yrs) |
4.207200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.557440E-03 |
| Normal-vs-Age(81-100Yrs) |
4.282300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.017000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.816800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.026400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.790400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.339000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.045600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.922100E-03 |
| Classical-VS-Follicular |
3.360800E-04 |
| Classical-VS-Other |
7.483400E-01 |
| Classical-VS-Normal |
3.72910000000504E-05 |
| Tall-VS-Follicular |
6.04140000026732E-07 |
| Tall-VS-Other |
2.567800E-01 |
| Tall-VS-Normal |
1.54139999986036E-07 |
| Follicular-VS-Other |
3.451200E-01 |
| Follicular-VS-Normal |
5.883200E-01 |
| Other-VS-Normal |
2.116600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.376500E-02 |
| Normal-vs-N1 |
1.86840000004906E-06 |
| N0-vs-N1 |
1.800140E-03 |
|
|
